Skip to search.
 FTSE 100 Up 0.24%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
13.42 Down 0.24(1.76%) 24 Apr 21:00
Add to Portfolio
Prev Close:13.66
Open:13.66
Bid:13.31 x 100
Ask:14.01 x 1000
1y Target Est:25.31
Beta:1.54
Next Earnings Date: 7-May-15SRPT Earnings announcement
Day's Range:13.37 - 13.78
52wk Range:11.33 - 38.25
Volume:273,347
Avg Vol (3m):757,451
Market Cap:554.97m
P/E (ttm):N/A
EPS (ttm):-3.39
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SRPTDown 1.76%554.97m
ALNYUp 0.24%9.97b
GSKUp 0.60%112.07b
ISISDown 2.03%7.90b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):57.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-4.21
Quarterly EPS Est (Mar-15) :-1.00
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):16.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback